Quarterly report pursuant to Section 13 or 15(d)

EQUITY TRANSACTIONS

v3.21.1
EQUITY TRANSACTIONS
3 Months Ended
Mar. 31, 2021
Stockholders' Equity Note [Abstract]  
Stockholders' Equity Note Disclosure [Text Block]

NOTE 5: STOCKHOLDERS EQUITY


Common Stock


During February and March 2021, the Company issued a total of 24,481,282 shares of its common stock to holders of convertible notes payable for principal totaling $170,000, accrued interest totaling $11,733 and conversion fees of $600.


During March 2021, an officer and director of the Company agreed to return and retire 4,516,310 shares of common stock previously issued for common stock compensation.


Common Stock Warrants


Warrants


There were no warrants issued during the three months ended March 31, 2021 and the year ended December 31, 2020. The following table presents the stock warrant activity during the three months ended March 31, 2021:


                   

Weighted

 
           

Weighted

   

Average

 
   

Warrants

   

Average Exercise Price

   

Remaining Term

 

Outstanding - December 31, 2020

    491,872     $ 0.14       0.43  

Granted

    -       -       -  

Forfeited/expired

    (240,000

)

    0.14       -  

Exercised

    -       -       -  

Outstanding March 31, 2021

    251,872     $ 0.15       0.50  

Exercisable – March 31, 2021

    251,872     $ 0.15       0.50  

The intrinsic value of the exercisable warrants as of March 31, 2021 was $0.